Gonadotropin releasing hormone analogue treatment of central precocious puberty is not associated with altered prevalence of polycystic ovary syndrome: a single center cohort study

BACKGROUND: There is conflicting evidence regarding an association between gonadotropin releasing hormone analogue (GnRHa) therapy and polycystic ovary syndrome (PCOS). This study aimed to compare the prevalence of endocrine disorders, primarily PCOS, between women who had been treated with GnRHa fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Karavani, Gilad, Chill, Henry H., Schachter-Safrai, Natali, Lomnitz, Gan, Gillis, David, Bauman, Dvora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442439/
https://www.ncbi.nlm.nih.gov/pubmed/34521474
http://dx.doi.org/10.1186/s40842-021-00129-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442439/
https://www.ncbi.nlm.nih.gov/pubmed/34521474
http://dx.doi.org/10.1186/s40842-021-00129-4

Ejemplares similares